Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6WG0

Crystal structure of Fab366 in complex with NPNA3 peptide from circumsporozoite protein

Summary for 6WG0
Entry DOI10.2210/pdb6wg0/pdb
DescriptorFab366 heavy chain, Fab366 light chain, NPNA3 peptide, ... (4 entities in total)
Functional Keywordsmalaria, sporozoite, circumsporozoite protein, antibody, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains3
Total formula weight48408.06
Authors
Pholcharee, T.,Oyen, D.,Wilson, I.A. (deposition date: 2020-04-04, release date: 2020-07-29, Last modification date: 2024-10-30)
Primary citationPholcharee, T.,Oyen, D.,Flores-Garcia, Y.,Gonzalez-Paez, G.,Han, Z.,Williams, K.L.,Volkmuth, W.,Emerling, D.,Locke, E.,Richter King, C.,Zavala, F.,Wilson, I.A.
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum.
Nat Commun, 12:1063-1063, 2021
Cited by
PubMed Abstract: The most advanced P. falciparum circumsporozoite protein-based malaria vaccine, RTS,S/AS01 (RTS,S), confers partial protection but with antibody titers that wane relatively rapidly, highlighting the need to elicit more potent and durable antibody responses. Here, we elucidate crystal structures, binding affinities and kinetics, and in vivo protection of eight anti-NANP antibodies derived from an RTS,S phase 2a trial and encoded by three different heavy-chain germline genes. The structures reinforce the importance of homotypic Fab-Fab interactions in protective antibodies and the overwhelmingly dominant preference for a germline-encoded aromatic residue for recognition of the NANP motif. In this study, antibody apparent affinity correlates best with protection in an in vivo mouse model, with the more potent antibodies also recognizing epitopes with repeating secondary structural motifs of type I β- and Asn pseudo 3 turns; such insights can be incorporated into design of more effective immunogens and antibodies for passive immunization.
PubMed: 33594061
DOI: 10.1038/s41467-021-21221-4
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.599 Å)
Structure validation

231029

数据于2025-02-05公开中

PDB statisticsPDBj update infoContact PDBjnumon